Xcout Intel
iOnctura competitors & alternatives
The 12 closest competitors and alternatives to iOnctura among healthcare companies — ranked by similarity to what iOnctura actually does, not by market-cap band.
Subscribe to see iOnctura’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About iOnctura
iOnctura is headquartered in Geneva, Switzerland, with research operations in Amsterdam, developing targeted cancer therapeutics.
iOnctura at a glance
iOnctura is a healthcare company headquartered in Switzerland. It has raised at least $107.7M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $86M in June 2024. Xcout tracks 13 named people at iOnctura, including Michelle Tsai (COO).
iOnctura leadership
- Michelle TsaiCOO
- Steven SciutoCFO
- Mark VellecaChair
- Elizabeth HoltCBO
- Michael LahnCMO
- Catherine PickeringCo-Founder, CEO
7 more named people on record for iOnctura, with roles, board committees and tenure — see the full roster →
iOnctura funding rounds
At least $107.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $86M | 4 named | |
| Series A | $21.6M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 iOnctura competitors
Ranked by semantic similarity — how close each company is to iOnctura by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
ACEA Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel medicines to improve the lives of patients with chronic and life-threatening diseases. The company focuses on oncology and targeted therapies through rigorous clinical research. Its global headquarters is located in San Diego, California, United States.
Similar healthcare company
HiberCell is a clinical-stage oncology company headquartered in New York, New York, with additional locations such as Roseville, Minnesota. It focuses on the discovery and development of therapeutics targeting cancer recurrence and resistance.
Similar healthcare company
Eigen Therapeutics is a biotechnology company headquartered in Redwood City, California, focused on developing 'priming' therapies that make cancer easier to find and eliminate.
Similar healthcare company
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
Health Care
Sprint Bioscience is a pharmaceutical company that develops innovative preclinical drug candidates for cancer treatments. Utilizing a fragment-based drug discovery method, the company creates and out-licenses its drug programs to global pharmaceutical partners.
Biotechnology
Inthera Bioscience AG is a Swiss biotechnology company focused on the discovery and development of targeted small molecule therapies, including modulators of intracellular protein-protein interactions, for the treatment of solid tumors. Headquartered in Zurich, the private company's pipeline features assets such as its lead oral small molecule candidate, INTH-454.
Biotechnology
InCephalo Therapeutics is a privately held biotechnology startup founded in 2021 and headquartered in Switzerland, with operations based in Schlieren and Allschwil. The company develops innovative, exclusively local treatments specifically targeting brain cancers.
Biotechnology
iOmx Therapeutics AG is a biopharmaceutical company located in Martinsried near Munich, Germany, dedicated to discovering and developing next-generation targeted cancer immunotherapies.
Biotechnology
InteRNA Technologies is a venture-backed biotech and life sciences company founded in 2008 and headquartered in Utrecht, Netherlands. The company specializes in the development of microRNA (miRNA)-focused drug pipelines and therapeutics. It operates within the biopharmaceutical sector, supported by various institutional backers and investors.
Biotech
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Biotechnology
IconOVir Bio, Inc. is a preclinical-stage biotechnology company headquartered in New York, United States, with a primary location in San Diego, California. Established in 2020, the venture-backed company is dedicated to pioneering novel oncolytic viral therapies to cure cancer and restore life to patients.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of iOnctura and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for iOncturaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →